COVID-19 induces a hyperactive phenotype in circulating platelets

Coronavirus Disease 2019 (COVID-19), caused by the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has affected over 30 million globally to date. Although high rates of venous thromboembolism and evidence of COVID-19-induced endothelial dysfunction have been reported, the precise...

Descripción completa

Detalles Bibliográficos
Autores principales: Comer, Shane P., Cullivan, Sarah, Szklanna, Paulina B., Weiss, Luisa, Cullen, Steven, Kelliher, Sarah, Smolenski, Albert, Murphy, Claire, Altaie, Haidar, Curran, John, O’Reilly, Katherine, Cotter, Aoife G., Marsh, Brian, Gaine, Sean, Mallon, Patrick, McCullagh, Brian, Moran, Niamh, Ní Áinle, Fionnuala, Kevane, Barry, Maguire, Patricia B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920383/
https://www.ncbi.nlm.nih.gov/pubmed/33596198
http://dx.doi.org/10.1371/journal.pbio.3001109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920383/
https://www.ncbi.nlm.nih.gov/pubmed/33596198
http://dx.doi.org/10.1371/journal.pbio.3001109

Ejemplares similares